IPO Date:2012-02-03

Company Profile

TP
Tonix Pharmaceuticals Holding Corp.

TNXP

Company Description

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company focused on developing innovative therapeutics to address significant unmet medical needs. Its pipeline includes treatments for central nervous system disorders, immunology, infectious diseases, and rare conditions. The company emphasizes novel small molecules and biologics, with a strong focus on advancing therapies through clinical trials to achieve regulatory approval and commercialization. Research efforts target conditions like fibromyalgia, PTSD, and Long COVID, leveraging cutting-edge science to improve patient outcomes. The firm collaborates with academic and industry partners to accelerate drug development and bring transformative treatments to market.

Most Profitable Insider Trade

Insiders

NameCIKPosition
loading...